The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Urinary incontinence, or leakage of urine, is a very common condition for women of all ages, ethnicities and backgrounds.

A football fan who has stage four prostate cancer is backing a campaign for sanitary bins to be put in men's toilets at ...

WHEN was the last time you thought about your pelvic floor? Maybe never? If so, it’s time to start paying some attention as ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...